15 Oct
2021

AbbVie suffers knock-back in Humira trade secrets dispute

Alvotech has received a boost going into dramatic final stages of its adalimumab biosimilar IP dispute with AbbVie, following a court decision to throw out a parallel trade secret suit

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth